For the quarter ending 2026-03-31, CRVO has $15,112,918 in assets. $4,497,203 in debts. $7,941,751 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 7,941,751 | 8,235,469 | 9,437,400 | 8,320,713 |
| Marketable securities | 4,982,230 | 12,628,970 | 17,856,688 | 25,210,453 |
| Prepaid expenses and other current assets | 1,695,341 | 1,267,005 | 1,685,972 | 1,964,327 |
| Deferred offering costs | 493,596 | 320,581 | 269,331 | 224,931 |
| Grant receivable | 0 | 426,993 | 1,361,387 | 2,360,975 |
| Total current assets | 15,112,918 | 22,879,018 | 30,610,778 | 38,081,399 |
| Total assets | 15,112,918 | 22,879,018 | 30,610,778 | 38,081,399 |
| Accounts payable | 2,272,497 | 1,454,118 | 1,349,219 | 1,845,609 |
| Accrued expenses and other current liabilities | 2,224,706 | 3,201,999 | 3,250,095 | 2,796,011 |
| Total current liabilities | - | 4,656,117 | - | - |
| Total liabilities | 4,497,203 | 4,656,117 | 4,599,314 | 4,641,620 |
| Common stock, 0.001 par value 1,000,000,000 shares authorized at march 31, 2026 and december 31, 2025 9,258,719 and 9,252,719 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 9,258 | 9,252 | 9,252 | 9,252 |
| Additional paid-in capital | 116,268,674 | 115,905,684 | 115,606,949 | 115,315,232 |
| Accumulated other comprehensive (loss) income | -208 | 5,816 | 5,824 | -783 |
| Accumulated deficit | -105,662,009 | -97,697,851 | -89,610,561 | -81,883,922 |
| Total stockholders' equity | 10,615,715 | 18,222,901 | 26,011,464 | 33,439,779 |
| Total liabilities and stockholders' equity | 15,112,918 | 22,879,018 | 30,610,778 | 38,081,399 |
CervoMed Inc. (CRVO)
CervoMed Inc. (CRVO)